Substudy Responses to Covid-19 vaccines in research Clinical picture, immunology, genetics and pathogenesis of COVID-19 infectio

Phase 1

• Conditions: one; Therapeutic area: Body processes [G] - Immune system processes [G12]

• Registration Number: EUCTR2021-004016-26-FI
• Lead Sponsor: Meilahti Vaccine Research Center - Helsinki University Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-09-14
• Last Update Posted: 26 October 2021

Recruitment & Eligibility

• Status: Authorised-recruitment may be ongoing or finished
• Sex: All
• Target Recruitment: 1000

Inclusion Criteria

1. Written informed consent.
2. >18 years old
3. Receiving Covid-19 vaccination despite of participating to this study. In this study we only investigate the responses and do not vaccinate participants.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 1000
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

1. Suspected non-compliance.

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified